Article
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.
Current treatment options in oncology - 1 Apr 2022
Rüchel Nadine, Jepsen Vera H, Hein Daniel, Fischer Ute, Borkhardt Arndt, Gössling Katharina L
Abstract excerpt
OPINION STATEMENT: Acute lymphoblastic leukemia (ALL) is the most frequent type of pediatric cancer with a peak incidence at 2-5 years of age. ALL frequently begins in utero with the emergence of clinically silent, preleukemic cells. Underlying leukemia-predisposing germline and acquired somatic mutations define distinct ALL subtypes that vary dramatically in treatment outcomes. In addition to genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
